Toripalimab plus bevacizumab as first-line treatment for advanced hepatocellular carcinoma: a single-arm phase II study

Category Primary study
JournalJournal of clinical oncology
Year 2022
This article has no abstract
Epistemonikos ID: ca1c6b64bc2e70bd8433662dc26b0eedd4294882
First added on: Dec 20, 2022